Clinical Trial

The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes

Study acronym: REST
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
To assess the efficacy of the REST model in facilitating adoption and sustained use of CGM, in older adults with Type 1 diabetes (T1D) or Type 2 Diabetes (T2D) on complex insulin regimens. To examine barriers and enablers for the implementation feasibility of the REST intervention model using a mixed-methods approach. To assess the impact of REST model on economic factors and quality of life measures. The goal of this study is to facilitate the adoption of continuous glucose monitoring (CGM) in older adults (≥65 years) with diabetes mellitus (DM) on complex insulin regimens, and additionally, to build a framework for sustained CGM use over time using a novel patient-centered model - the REST model.
Protocol Amendment History 1 change
minor Completion pushed: 2026-05 -> 2026-09 2026-08-11
Trial Details
NCT Number NCT05337826
Lead Sponsor Joslin Diabetes Center
Collaborators: State University of New York - Upstate Medical University, Cecilia Health
Conditions Diabetes Mellitus
Enrollment 122 participants
Start Date 2022-04-20
Primary Completion 2025-11-11 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-10